Percutaneous transluminal coronary angioplasty in a child with Kawasaki disease

J H Min1, J Huh, Y W Kim

  • 1Department of Pediatrics, Seoul National University College of Medicine, Korea.

Insights

Percutaneous transluminal coronary angioplasty (PTCA) successfully treated mid-left anterior descending artery stenosis in a child with Kawasaki disease. This intervention prevented further myocardial damage, highlighting early PTCA for subclinical stenosis.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Kawasaki Disease Research

Background:

  • Kawasaki disease frequently causes coronary artery aneurysms and stenosis in children.
  • Long-term sequelae include myocardial ischemia and infarction due to progressive coronary stenosis.
  • Management of significant stenosis in pediatric patients remains a challenge.

Observation:

  • A 6-year-old boy with Kawasaki disease presented with multiple coronary aneurysms and stenosis.
  • Despite 4 years of follow-up, he developed significant stenosis (70%) in the mid-left anterior descending artery.
  • Myocardial perfusion defects were noted on 99mTc-MIBI SPECT with dipyridamole infusion.

Findings:

  • Successful percutaneous transluminal coronary angioplasty (PTCA) reduced stenosis from 70% to 20%.
  • Angiography at 26 months showed no restenosis at the intervention site.
  • The patient remained asymptomatic with improved myocardial perfusion post-procedure.

Implications:

  • Early PTCA can be a safe and effective treatment for subclinical coronary stenosis in pediatric patients with Kawasaki disease.
  • This approach may prevent ischemic cardiac damage and improve long-term outcomes.
  • Consideration of early intervention strategies is crucial for managing coronary sequelae of Kawasaki disease.